Faster Cures Innovator Spotlight Features Cure Duchenne

FasterCures features a Q&A with Debra Miller, founder and CEO of CureDuchenne, in their Innovator Spotlight. FasterCures, a center of the Milken Institute, is an action tank driven by a singular goal – to save lives by speeding up and improving the medical research system.

The Q&A highlights CureDuchenne’s successful venture philanthropy model.  It focuses on what prompted the creation of CureDuchenne to CureDuchenne’s research and development strategies and the organizations accomplishments including three projects CureDuchenne funded – Prosensa Holdings, Sarepta Therapeutics and PTC Therapeutics – that are the closest to being the first drugs to be approved for the treatment of Duchenne.

Click here to review the article.



Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.